Gilead Sciences (NASDAQ:GILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada ...

"The CDC must be investigated for its misuse of PEPFAR funds," said Sen. Jim Risch (R-Idaho), following a report that funds ...

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...

After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a ...

Scientists discovered that repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will ...

In April 2021, the CDC came to Charleston — the seat of Kanawha County and the state capital, tucked into the confluence of ...

A major U.S. HIV/AIDS relief program is facing potential blowback amid reports that the program was used to fund abortions in southeast Africa.

In its litigation, the government alleged Gilead (GILD) had overstated its contribution in developing a preventive HIV regimen with the drug, ignored the CDC's contributions and failed to license ...